| Name | Fmoc-D-Pipecolic Acid |
|---|---|
| Synonyms |
MFCD00235899
1,2-Piperidinedicarboxylic acid, 1-(9H-fluoren-9-ylmethyl) ester, (2S)- (R)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperidine-2-carboxylic acid (2R)-1-[(9H-Fluoren-9-ylmethoxy)carbonyl]piperidine-2-carboxylic acid 1,2-Piperidinedicarboxylic acid, 1-(9H-fluoren-9-ylmethyl) ester, (2R)- (2S)-1-[(9H-Fluoren-9-ylmethoxy)carbonyl]-2-piperidinecarboxylic acid (2R)-1-[(9H-Fluoren-9-ylmethoxy)carbonyl]-2-piperidinecarboxylic acid (2S)-1-[(9H-Fluoren-9-ylmethoxy)carbonyl]piperidine-2-carboxylic acid Fmoc-D-Homoproline FMOC-D-PIPECOLIC ACID (2R)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]hexahydropyridine-2-carboxylic acid Fmoc-D-HomoPro-OH |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 561.6±43.0 °C at 760 mmHg |
| Melting Point | 149-153°C |
| Molecular Formula | C21H21NO4 |
| Molecular Weight | 351.396 |
| Flash Point | 293.5±28.2 °C |
| Exact Mass | 351.147064 |
| PSA | 66.84000 |
| LogP | 3.57 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.620 |
| Storage condition | 2-8°C |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26;S36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2933399090 |
|
~81%
101555-63-9 |
| Literature: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.; Gopalakrishnan, Ranganath; Hausch, Felix Patent: EP2607352 A1, 2013 ; Location in patent: Paragraph 0111 ; |
|
~82%
101555-63-9 |
| Literature: MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.; GOPALAKRISHNAN, Ranganath; HAUSCH, Felix Patent: WO2013/91900 A1, 2013 ; Location in patent: Page/Page column 41 ; |
|
~51%
101555-63-9 |
| Literature: Blizzard, Timothy A.; Singh, Sanjay; Patil, Basanagoud; Chidurala, Naresh; Komanduri, Venukrishnan; Debnath, Samarpita; Belyakov, Sergei; Crespo, Alejandro; Struck, Alice; Kurtz, Marc; Wiltsie, Judyann; Shen, Xun; Sonatore, Lisa; Arocho, Marta; Lewis, Dale; Ogletree, Martin; Biftu, Tesfaye Bioorganic and Medicinal Chemistry Letters, 2014 , vol. 24, # 4 p. 1111 - 1115 |
|
~84%
101555-63-9 |
| Literature: Gopalakrishnan, Ranganath; Kozany, Christian; Gaali, Steffen; Kress, Christoph; Hoogeland, Bastiaan; Bracher, Andreas; Hausch, Felix Journal of Medicinal Chemistry, 2012 , vol. 55, # 9 p. 4114 - 4122 |
|
~62%
101555-63-9 |
| Literature: Schoen, Istvan; Kisfaludy, Lajos Synthesis, 1986 , # 4 p. 303 - 305 |
|
~%
101555-63-9 |
| Literature: Journal of Organic Chemistry, , vol. 57, # 16 p. 4394 - 4400 |
|
~%
101555-63-9 |
| Literature: Journal of Organic Chemistry, , vol. 76, # 16 p. 6686 - 6693 |
| Precursor 7 | |
|---|---|
| DownStream 1 | |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |